Kellerhals Carrard advised BVF on the deal while Sheppard Mullin served as counsel to Laidlaw & Company (UK) Ltd. NLS Pharmaceutics Ltd. (NASDAQ: NLSP), a Swiss...
NLS Pharmaceutics’ $30 Million Purchase Agreement with BVF Partners L.P.
Silo Pharma’s $5.75 Million Public Offering and Nasdaq Uplisting
Sichenzia Ross Ference represented Laidlaw & Company (UK) Ltd. în the transaction while Sheppard Mullin advised Silo Pharma. Silo Pharma, Inc. (Nasdaq: SILO) announced the $5.75 million...